Tumor endothelial cell autophagy is a key vascular‐immune checkpoint in melanoma
EMBO Molecular Medicine · 07.12.2023 · 15 (12)
DOI: 10.15252/emmm.202318028 ↗Kurz gefasst
Fachartikel in der Zeitschrift EMBO Molecular Medicine, online erschienen am 27.11.2023. Verfasst von Jelle Verhoeven und 24 weiteren Autor:innen. Beteiligte Einrichtung: Cell Death Research and Therapy Laboratory, Center for Cancer Biology, VIB, Leuven, Belgium. Hauptthemen laut MEDLINE: Melanoma. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EOS, EOS DECODE, EOS MetaNiche.
Abstract (Originalsprache)
Tumor endothelial cells (TECs) actively repress inflammatory responses and maintain an immune‐excluded tumor phenotype. However, the molecular mechanisms that sustain TEC‐mediated immunosuppression remain largely elusive. Here, we show that autophagy ablation in TECs boosts antitumor immunity by supporting infiltration and effector function of T‐cells, thereby restricting melanoma growth. In melanoma‐bearing mice, loss of TEC autophagy leads to the transcriptional expression of an immunostimulatory/inflammatory TEC phenotype driven by heightened NF‐kB and STING signaling. In line, single‐cell transcriptomic datasets from melanoma patients disclose an enriched Inflammatory High /Autophagy Low TEC phenotype in correlation with clinical responses to immunotherapy, and responders exhibit an increased presence of inflamed vessels interfacing with infiltrating CD8 + T‐cells. Mechanistically, STING‐dependent immunity in TECs is not critical for the immunomodulatory effects of autophagy ablation, since NF‐kB‐driven inflammation remains functional in STING/ATG5 double knockout TECs. Hence, our study identifies autophagy as a principal tumor vascular anti‐inflammatory mechanism dampening melanoma antitumor immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell Death Research and Therapy Laboratory, Center for Cancer Biology, VIB, Leuven, Belgium.
- Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
- Laboratory of Translational Genetics, Center for Cancer Biology, VIB, Leuven, Belgium.
- Department of Human Genetics, KU Leuven, Leuven, Belgium.
- Laboratory of Tumor Microenvironment and Therapeutic Resistance Center for Cancer Biology, VIB, Leuven, Belgium.
- Department of Oncology, KU Leuven, Leuven, Belgium.
ORCID-Profile: Jelle Verhoeven, Kathryn A Jacobs, Francesca Rizzollo, Francesca Lodi, Yichao Hua, Sanket More, Oliver Bechter, Madhur Agrawal, Patrizia Agostinis
Förderung
- EOS
- EOS DECODE
- EOS MetaNiche
- Fonds Wetenschappelijk Onderzoek (FWO)
- iBOF-Atlantis
- Stichting Tegen Kanker (Fondation Contre le Cancer)
- UGhent
- iBOF‐Atlantis
Zitieren
APA
Verhoeven, J., Jacobs, K. A., Rizzollo, F., Lodi, F., Hua, Y., Poźniak, J., Narayanan Srinivasan, A., Houbaert, D., Shankar, G., More, S., Schaaf, M. B., Dubroja Lakic, N., Ganne, M., Lamote, J., Van Weyenbergh, J., Boon, L., Bechter, O., Bosisio, F., Uchiyama, Y., …, & Agostinis, P. (2023). Tumor endothelial cell autophagy is a key vascular‐immune checkpoint in melanoma. EMBO Molecular Medicine, 15(12). https://doi.org/10.15252/emmm.202318028
Vancouver
Verhoeven J, Jacobs KA, Rizzollo F, Lodi F, Hua Y, Poźniak J, et al. Tumor endothelial cell autophagy is a key vascular‐immune checkpoint in melanoma. EMBO Molecular Medicine. 2023;15(12). doi:10.15252/emmm.202318028
BibTeX
@article{Verhoeven2023,
author = {Verhoeven, Jelle and Jacobs, Kathryn A and Rizzollo, Francesca and Lodi, Francesca and Hua, Yichao and Poźniak, Joanna and Narayanan Srinivasan, Adhithya and Houbaert, Diede and Shankar, Gautam and More, Sanket and Schaaf, Marco B and Dubroja Lakic, Nikolina and Ganne, Maarten and Lamote, Jochen and Van Weyenbergh, Johan and Boon, Louis and Bechter, Oliver and Bosisio, Francesca and Uchiyama, Yasuo and Bertrand, Mathieu Jm and Marine, Jean Christophe and Lambrechts, Diether and Bergers, Gabriele and Agrawal, Madhur and Agostinis, Patrizia},
title = {Tumor endothelial cell autophagy is a key vascular‐immune checkpoint in melanoma},
journal = {EMBO Molecular Medicine},
year = {2023},
volume = {15},
number = {12},
doi = {10.15252/emmm.202318028}
}
EUVIMED